Effects of gender on intracellular [Ca2+] in rat cardiac myocytes

Pflugers Archiv European Journal of Physiology

Volumn 441, Issue 5, 2001, Pages 709-716

  Curl, C L ^a   Wendt, I R ^a   Kotsanas, G ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Caffeine; Calcium; Cardiomyocyte; Fura 2; Gender; Isoprenaline

Indexed keywords

CAFFEINE; ISOPRENALINE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; GENDER; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CAFFEINE; CALCIUM; FEMALE; FLUORESCENT DYES; FURA-2; ISOPROTERENOL; MALE; MUSCLE FIBERS; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, WISTAR; SEX CHARACTERISTICS;

EID: 0035115233     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004240000473     Document Type: Article

References (35)

1. Estrogen and coronary heart disease in women
2. Relaxation in rabbit and rat cardiac cells: Species-dependent differences in cellular mechanisms
3. Influence of sex, diabetes and ethanol on intrinsic contractile performance of isolated rat myocardium
4. Sex differences in myocardial contractility in the rat
5. Benefit/risk of estrogen therapy in cardiovascular disease: Current knowledge and future challenges
6. Changes in the calcium current of rat heart ventricular myocytes during development
7. Cardiovascular protection by oestrogen - A calcium antagonist effect?
8. The vascular protective effects of estrogen
9. Response of heart rate to acute administration of isoproterenol in rats treated chronically with norethynodrel, ethinyl estradiol, and both combined
10. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults
11. How do we explain the clinical benefits of estrogen? From bedside to bench
12. Hormone therapy to prevent disease and prolong life in postmenopausal women
13. Modulation of hypertensive heart disease by estrogen
14. Cardiac myocytes and fibroblasts contain functional estrogen receptors
15. 2+ indicators with greatly improved fluorescence properties
16. 2+ release induced by thromboxane A2 in porcine coronary artery
17. 2+ in guinea-pig isolated cardiac myocytes
18. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice
19. 2+] with fluorescent indicators
20. Effects of beta-adrenoceptor stimulation on intracellular Ca transients and tension in rat ventricular muscle
21. Age and gender differences in excitation-contraction coupling of the rat ventricle
22. Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat
23. 2+ current in aortic smooth muscle cells
24. Modulation of cardiac hypertrophy by estrogens
25. Depressed cardiac sarcoplasmic reticular function from diabetic rats
26. Effects of 17 beta-estradiol on the isolated rabbit heart
27. Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium
28. Comparison of heart function in male and female rats
29. Investigation of the negative inotropic effects of 17 beta-oestradiol in human isolated myocardial tissues
30. 2+ current in cardiac myocytes
31. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
32. The heart: A target organ for estradiol
33. Phosphorylation of the sarcoplasmic reticulum and sarcolemma
34. Age associated changes in membrane currents in rat ventricular myocytes
35. Age-associated changes in beta-adrenergic modulation on rat cardiac excitation-contraction coupling